Response to "helping melanoma patients decide whether to choose adjuvant high-dose interferon-alpha2b".
Tarhini
Ahmad A
AA
Shipe-Spotloe
Janice
J
DeMark
Melissa
M
Agarwala
Sanjiv S
SS
Kirkwood
John M
JM
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D003657:Decision Making; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008545:Melanoma / Q000188:drug therapy*; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins